Abramson Cancer Center
Healthy Volunteers Study
- Conditions
- Ovarian CancerGenetic Predisposition to Disease
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT06962059
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
- Conditions
- Lung CancersGastrointestinal Cancers
- First Posted Date
- 2025-05-02
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT06955468
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)
- Conditions
- Geriatric AssessmentAdvanced CancerToxicity
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 150
- Registration Number
- NCT06870617
- Locations
- 🇺🇸
Penn Medicine Princeton Medical Center, Princeton, New Jersey, United States
🇺🇸Lancaster General Hospital, Lancaster, Pennsylvania, United States
🇺🇸Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
- Conditions
- Head and Neck CancerLymphedema of the Head and Neck
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 150
- Registration Number
- NCT06837480
- Locations
- 🇺🇸
University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Head Stabilization in Whole Brain RT
- Conditions
- Brain Cancer
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT06776406
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)
- Conditions
- Renal Cell Carcinoma
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 23
- Registration Number
- NCT06770855
- Locations
- 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States
Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Interventions
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 68
- Registration Number
- NCT06747845
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Patient Ambassador
- Conditions
- Gynecologic Cancer
- First Posted Date
- 2024-12-02
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 23
- Registration Number
- NCT06711380
- Locations
- 🇺🇸
Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Assessing Perceptions of ML Explanations by Medical Oncologists
- Conditions
- Oncology
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT06699615
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
An Analysis of Medication Adherence Using Televideo and Telephonic Monitoring and Utilization of an Education Protocol
- Conditions
- Adherence, MedicationCancer
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 76
- Registration Number
- NCT06696521
- Locations
- 🇺🇸
Abramson Cancer Center at PPMC, Philadelphia, Pennsylvania, United States